What is the best biomarker to assess arsenic exposure via drinking water?

Environment International

Volumn 39, Issue 1, 2012, Pages 150-171

  Marchiset Ferlay, Nathalie ^a   Savanovitch, Chantal ^a   Sauvant Rochat, Marie Pierre ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Arsenic; Biomarker; Drinking water; Epidemiological study; Human health; Risk assessment

Indexed keywords

ARSENIC; BIOMARKERS; BLOOD; DAMAGE DETECTION; HEALTH RISKS; PORPHYRINS; RISK ASSESSMENT;

ADVERSE EFFECT; ARSENIC EXPOSURE; AS SPECIATION; CHROMOSOMAL ABERRATION; CHRONIC EFFECTS; CHRONIC INTOXICATION; DNA DAMAGES; EARLY EFFECTS; ENVIRONMENTAL EPIDEMIOLOGY; EPIDEMIOLOGICAL STUDIES; GENOTOXIC EFFECTS; HUMAN HEALTH; LONG TERM EXPOSURE; POPULATION SURVEY; POTENTIAL EFFECTS; SISTER CHROMATID EXCHANGE;

POTABLE WATER;

ARSENIC; ARSENIC DERIVATIVE; BIOLOGICAL MARKER; DIMETHYLDITHIOARSINIC ACID; DIMETHYLMONOTHIOARSINIC ACID; DRINKING WATER; METHYLMONOTHIOARSONIC ACID; PORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG;

ARSENIC; BIOMARKER; DRINKING WATER; EPIDEMIOLOGY; GENOTOXICITY; HEALTH IMPACT; POLLUTION EXPOSURE; RISK ASSESSMENT; SPECIATION (CHEMISTRY); WORLD HEALTH ORGANIZATION;

ARSENIC METABOLISM; ARSENIC POISONING; BIOLOGICAL MONITORING; BLOOD LEVEL; CELL ASSAY; CHEMICAL ANALYSIS; CHROMOSOME ABERRATION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; CYTOGENETICS; CYTOTOXICITY; DISEASE PREDISPOSITION; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; GENOTOXICITY; HAIR ANALYSIS; HAIR LEVEL; HEALTH HAZARD; HEALTH SURVEY; HUMAN; METAL METABOLISM; MICRONUCLEUS; MICRONUCLEUS TEST; NAIL; NONHUMAN; OXIDATIVE STRESS; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH SERVICE; REFERENCE VALUE; REVIEW; SISTER CHROMATID EXCHANGE; URINALYSIS; URINARY EXCRETION; URINE LEVEL; WATER CONTAMINATION; WORLD HEALTH ORGANIZATION;

EID: 82355187608     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2011.07.015     Document Type: Review

References (213)

1. Adair B.M., Hudgens E.E., Schmitt M.T., Calderon R.L., Thomas D.J. Total arsenic concentrations in toenails quantified by two techniques provide a useful biomarker of chronic arsenic exposure in drinking water. Environ Res 2005, 101:213-220.
2. Ahsan H., Chen Y., Kibriya M.G., Slavkovich V., Parvez F., Jasmine F., et al. Arsenic metabolism, genetic susceptibility and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev 2007, 16:1270-1278.
3. Aitio A., Bernard A., Fowler B.A., Nordberg G.F. Biological monitoring and biomarkers. Handbook on the toxicology of metals 2007, 65-78. Academic Press/Elsevier, (Chapter 4). 3rd ed. G.F. Nordberg (Ed.).
4. Antelmi A., Lovreglio P., Drago I., Greco L., Meliddo G., Manghisi M.S., et al. Significance and limitation of creatinine adjustment for urinary chromium and arsenic in biological monitoring of occupational exposure to these metallic elements. G Ital Med Lav Ergon 2007, 29:288-291.
5. Anwar M. Arsenic, cadmium and lead levels in hair and toenail samples in Pakistan. Environ Sci 2005, 12:71-86.
6. Aposhian M.M. Occurrence of monomethly arsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 2000, 13:693-697.
7. Aposhian H.V., Gurzau E.S., Le X.C., Gurzau A., Healy S.M., Lu X., et al. Enzymatic methylation of arsenic compounds. II. An overview. Arsenic, exposure and health effects 1997, 296-321. Chapman and Hall, London. C.O. Abernathy, R.L. Calderon, W.R. Chappell (Eds.).
8. Apostoli P., Bartoli D., Alessio L., Buchet J.P. Biological monitoring of accupational exposure to inorganic arsenic. Occup Environ Med 1999, 56:825-832.
9. Apostoli P., Sarnico M., Bavazzano P., Bartoli D. Arsenic and porphyrins. Am J Ind Med 2002, 42:180-187.
10. Barr D.B., Caudill S.P., Jones R.L., Pfeiffer C.M., Pirkle J.L. Urinary creatinine: Barr et al. respond. Environ Health Perspect 2005, 113:A442.
11. Barr D.B., Wilder L.C., Caudill S.P., Gonzalez A.J., Needham L.L., Pirkle J.L. Urinary creatinine concentrations in the US population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005, 113:192-200.
12. Basu A., Mahata J., Gupta S., Giri A.K. Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat Res 2001, 488:171-194.
13. Basu A., Mahata J., Roy A.K., Sarkar J.N., Poddar G., Nandy A.K., et al. Enhanced frequency of micronuclei in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res 2002, 516:29-40.
14. Basu A., Ghosh P., Das J.K., Banerjee A., Ray K., Giri A.K. Micronuclei as biomarkers of carcinogen exposure in populations exposed to arsenic through drinking water in West Bengal, India: a comparative study in three cell types. Cancer Epidemiol Biomarkers Prev 2004, 14:820-827.
15. Bemramdane L., Accominotti M., Fanton L., Malicier D., Vallon J.J. Arsenic speciation in human organs following fatal arsenic trioxide poisoning-a case report. Clin Chem 1999, 45:301-306.
16. Biggs M.L., Kalman D.A., Moore L.E., Hopenhayn-Rich C., Smith M.T., Smith A.H. Relationship of urinary arsenic to intake estimates and a biomarker of effect, bladder cell micronuclei. Mutat Res 1997, 386:185-195.
17. Biswas S., Talukder G., Sharma A. Prevention of cytotoxic effects of arsenic by short-term dietary supplementation with selenium in mice in vivo. Mutat Res 1999, 441:155-160.
18. Bonassi S., Znaor A., Ceppi M., Lando C., Chang W.P., Holland N., et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007, 28:625-631.
19. Brima E.I., Haris P.I., Jenkins R.O., Polya D.A., Gault A.G., Harrington C.F. Understanding arsenic metabolism through a comparative study in the urine, hair and fingernail of healthy volunteers from three unexposed ethnic groups in the United Kingdom. Toxicol Appl Pharmacol 2006, 216:122-130.
20. Brima E.I., Jenkins R.O., Lythgoe P.R., Gault A.G., Polya D.A., Haris P.I. Effect of fasting on the pattern of urinary arsenic excretion. J Environ Monit 2007, 9:98-103.
21. Caceres D.D., Pino P., Montesinos N., Atalah E., Amigo H., Loomis D. Exposure to inorganic arsenic in drinking water and total urinary arsenic concentration in a Chilean population. Environ Res 2005, 98:151-159.
22. Caceres D.D., Werlinger F., Orellana M., Jara M., Rocha R., Alvarado S.A., et al. Polymorphism of glutathione S-transferase (GST) variants and its effect on distribution of urinary arsenic species in people exposed to low inorganic arsenic in taps water: an exploratory study. Arch Environ Occup Health 2010, 65(3):140-147.
23. Calderon R.L., Hudgens E., Le X.C., Schreinemachers D., Thomas D.J. Excretion of Arsenic as a function of exposure to Arsenic in drinking water. Environ Health Perspect 1999, 107:663-667.
24. Cavar S., Klapec T., Grubesic R.J., Valek M. High exposure to arsenic from drinking water at several localities in eastern Croatia. Sci Total Environ 2005, 339:277-282.
25. Chakraborty T., Das U., Poddar S., Sengupta B., De M. Micronuclei and chromosomal aberrations as biomarkers: a study in an arsenic exposed population in West Bengal, India. Bull Environ Contam Toxicol 2006, 76:970-976.
26. Chen K.P., Wu H.Y., Wu T.C. Epidemiologic studies on Blackfoot Disease (BFD) in Taïwan 3: physicochemical characteristics of drinking water in endemic BFD areas. Mem Coll Med Nat Taiwan Univ 1962, 8:115-129.
27. Chen Y.C., Amarasiriwardena C.J., Hsueh Y.M., Christiani D.C. Stability of arsenic species and insoluble arsenic in human urine. Cancer Epidemiol Biomarkers 2002, 11:1427-1433.
28. Chen Y.C., Guo Y.L., Su H.J., Hsueh Y.M., Smith T.J., Ryan L.M. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 2003, 14:303-310.
29. Chen C.J., Hsu L.I., Wang C.H., Shih W.L., Hsu Y.H., Tseng M.P., et al. Biomarkers of exposure, effect and susceptibility of arsenic induced health hazards in Taiwan. Toxicol Appl Pharmacol 2005, 206:198-206.
30. Chiou H.Y., Hsueh Y.M., Hsieh L.L., Hsu L.I., Hsu Y.H., Hsieh F.I., et al. Arsenic methylation capacity, body retention and null genotypes of glutathione S-transférase M1 and T1 among current arsenic exposed residents in Taiwan. Mutat Res 1997, 386:197-207.
31. Chowdbury U.K., Rahman M.M., Sengupta M.K., Lodh D., Chanda C.R., Roy S., et al. Pattern of excretion of arsenic compounds (arsenite, arsenate, MMA(V), DMA (V)) in urine of children compared to adults from an arsenic exposed area in Bangladesh. J Environ Sci Health A Tox Hazard Subst Environ Eng 2003, 38:87-113.
32. Chung J.S., Kalman D.A., Moore L.E., Kosnett M.J., Arroyo A.P., Beeris M., et al. Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water. Environ Health Perspect 2002, 110:729-733.
33. Concha G., Nermell B., Vahter M. Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. Environ Health Perspect 1998, 106:355-359.
34. Concha G., Vogler G., Nermell B., Vahter M. Intra-individual variation in the metabolism of inorganic arsenic. Int Arch Occup Environ Health 2002, 75:576-580.
35. Concha G., Nermell B., Vahter M. Spatial and temporal variations in arsenic exposure via drinking water in northern Argentina. J Health Popul Nutr 2006, 24:317-326.
36. Daniel C.R., Piraccini B.M., Tosti A. The nail and hair in forensic science. J Am Acad Dermatol 2004, 50:258-261.
37. De Vizcaya-Ruiz A., Barbier O., Ruiz-Ramos R. Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat Res 2009, 674:85-92.
38. Del Razo L.M., Garcia-Vargas G.G., Vargas H., Albores A., Gonsebatt M.E., Montero R., et al. Altered profile of urinary metabolites in adults with chronic arsenicism. Arch Toxicol 1997, 71:211-217.
39. Del Razo L.M., Quintanilla-Vega B., Brambila-Colombres E., Calderon-Aranda E., Manno M., Albores A. Stress proteins induced by arsenic. Toxicol Appl Pharmacol 2001, 177:132-148.
40. Del Razo L.M., Styblo M., Cullen W.R., Thomas D.J. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol 2001, 174:282-293.
41. Deng G.D., Zheng B.S., Zhai C., Wang J.P., Ng J.C. Porphyrins as the early biomarkers for arsenic exposure of human. Huan Jing Ke Xue 2007, 28:1147-1152.
42. Dictor M.C., Baranger P., Chéry L., Michel K., Barbier J., Clozel B., et al. Synthèse des travaux de recherche et développement en France (1999-2003) sur la thématique arsenic. Rapport final. BRGM/RP53252-FR 2004, 130 p; 4III; 3 Ann.
43. Dulout F.N., Grillo C.A., Seoane A.I., Maderna C.R., Nisson R., Vahter M., et al. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. Mutat Res 1996, 370:151-158.
44. Ebdon L., Fisher A., Roberts N., Yaqoob M. Determination of organoarsenic species in blood plasma by HPLC-ICP MS. Appl. Organometal. Chem. 1999, 13:183-187.
45. Engström K., Vahter M., Mlakar S.J., Concha G., Nermell B., Raqib R., et al. Polymorphisms in arsenic (+III oxidate state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism. Environ Health Perspect 2011, 119:182-188.
46. Eslava O. Tests de génotoxicité : utilité en Médecine du Travail-Difficultés lors de son application à la surveillance médicale des travailleurs. Arch Public Health 2004, 62:71-81.
47. Fujihara J., Kunito T., Toshihiro Y., Iida R., Fujii Y., Takeshita H. Population differences in the human arsenic (+3 oxidation state) methyltranferase (As3MT) gene polymorphism detected by genotyping method. Toxicol Appl Pharmacol 2007, 225:251-254.
48. Gamble M.V., Liu X. Urinary creatinine and arsenic metabolism. Environ Health Perspect 2005, 113:A442.
49. Gamble M.V., Liu X., Ahsan H., Pilsner J.R., Ilievski V., Slavkovich V., et al. Folate, homocysteine and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 2005, 113:1683-1688.
50. Gamble M.V., Liu X., Ahsan H., Pilsner J.R., Ilievski V., Slavkovich V., et al. Folate and arsenic metabolism: a double blind, placebo controlled folic acid supplementation trial in Bangladesh. Am J Clin Nutr 2006, 84:957-958.
51. Garcia-Vargas G., Hernandez-Zavala A. Urinary porphyrins and heme biosynthetic enzyme activities measured by HPLC in arsenic toxicity. Biomed Chromatogr 1996, 10:278-284.
52. Garcia-Vargas G.G., Del Razo L.M., Cebrian M.E., Albores A., Ostrosky-Wegman P., Montero R., et al. Altered urinary porphyrin excretion in a human population chronically exposed to arsenic in Mexico. Hum Exp Toxicol 1994, 13:839-847.
53. Gebel T.W. Genotoxicity of arsenical compounds. Int J Hyg Environ Health 2001, 203:249-262.
54. Gebel T.W., Leister M., Schumann W., Hirsch-Ernst K. Low-level self-tolerance to arsenite in human HepG2 cells is associated with a depressed induction of micronuclei. Mutat Res 2002, 514:245-255.
55. Ghosh P., Basu A., Mahata J., Basu S., Sengupta M., Das J.K., et al. Cytogenetic damage and genetic variants in the individuals susceptible to arsenic induced cancer through drinking water. Int J Cancer 2006, 118:2470-2478.
56. Ghosh P., Banerjee M., de Chaudhuri S., Das J., Sarma N., Basu A., et al. Increased chromosome aberration frequencies in the Bowen's patients compared to non cancerous skin lesions individuals exposed to arsenic. Mutat Res 2007, 632:104-110.
57. Gigante M.R., Antelmi A., Iavicoli S., Persechino B., Drago I., Conversano M., et al. Evaluation of the role of occupational and environmental exposure to inorganic acid in the urinary excretion of the metal: preliminary data. G Ital Med Lav Ergon 2006, 28:199-201.
58. Goering P.L., Aposhian H.V., Mass M.J., Cebrian M., Beck B.D., Walls M.P. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci 1999, 49:5-14.
59. Gomez-Caminero A., Howe P., Hughes M., Kenyon E., Lewis D.R., Moore M., et al. Arsenic and arsenic coumpounds. Environmental health criteria 2001, 224. World Health Organization, Geneva, 501 pp. 2nd ed.
60. Gomez-Rubio P., Roberge J., Arendell L., Harris R.B., O'Rourke M.K., Chen Z., et al. Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico. Toxicol Appl Pharmacol 2011, 252:176-182.
61. Gong Z., Lu X., Cullen W.R., Le X.C. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J Anal Spectrom 2001, 198:1409-1413.
62. Gonsebatt M.E., Vega L., Salazar A.M., Montero R., Guzman P., Blas J., et al. Cytogenetic effects in human exposure to arsenic. Mutat Res 1997, 386:219-228.
63. Goyer R.A. Toxic effects of metals. Casarett and Doull's toxicology: the basic science of the poisons 1996, 691-736. Mc Graw-Hill, New-York. 5th ed. I. Casarett, J. Louis, C. Klaassen, M. Amdur, S. Doull (Eds.).
64. Hall M., Chen Y., Ahsan H., Slavkovich V., van Geen A., Parvez F., et al. Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology 2006, 225:225-233.
65. Hall M.N., Liu X., Slavkovich V., Ilievski V., Pilsner J.R., Alam S., et al. Folate, cobalamin, cysteine, homocysteine and arsenic metabolism among children in Bangladesh. Environ Health Perspect 2009, 117:825-831.
66. Hansen H.R., Raab A., Jaspars M., Milne B.F., Feldmann J. Sulfur containing arsenical mistaken for dimethylarsinous acid [DMA(III)] and identified as a natural metabolite in urine: major implications for studies on arsenic metabolism and toxicity. Chem Res Toxicol 2004, 17:1086-1091.
67. Hayakawa T., Kobayashi Y., Cui X., Hirano S. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch Toxicol 2005, 79:183-191.
68. Heck J.E., Gamble M.V., Chen Y., Graziano J.H., Slavkovich V., Parvez F., et al. Consumption of folate related nutrients and metabolism of arsenic in Bangladesh. Am J Clin Nutr 2007, 85:1367-1374.
69. Hernandez-Zavala A., Del Razo L.M., Garcia-Vargas G.G., Aguilar C., Borja V.H., Albores V.H., et al. Altered activity of heme biosynthesis pathway enzymes in individuals chronically exposed to arsenic in Mexico. Arch Toxicol 1999, 73:90-95.
70. Hindmarsh J.T. Caveats in hair analysis in chronic arsenic poisoning. Clin Biochem 2002, 35:1-11.
71. Hinwood A.L., Sim M.R., Jolley D., de Klerk N., Bastone E.B., Gerostamoulos J. Hair and toenails arsenic concentrations of residents living in areas with high environmental arsenic concentrations. Environ Health Perspect 2003, 111:187-193.
72. Hirano S., Kobayashi Y., Cui X., Kanno S., Hayakawa T., Shraim A. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol Appl Pharmacol 2004, 198:458-467.
73. Hopenhayn C., Huang B., Christian J., Peralta C., Ferrecio C., Atallah R., et al. Profile of urinary arsenic metabolites during pregnancy. Environ Health Perspect 2003, 111:1888-1891.
74. Hopenhayn-Rich C., Biggs M.L., Smith A.H., Kalman D.A., Moore L.E. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect 1996, 104:620-628.
75. Hsu Y.H., Li S.Y., Chiou H.Y., Yeh P.M., Liou J.C., Hsueh Y.M., et al. Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowen's disease patients and matched controls of arseniasis-hyperendemic villages in Taiwan. Mutat Res 1997, 386:241-251.
76. Hsueh Y.M., Chiou Y.L., Huang Y.L., Wu W.L., Huang C.C., Yang M.H. Serum beta-carotene level, arsenic methylation capability and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev 1997, 6:589-596.
77. Huang Y.K., Pu Y.S., Chung Y.S., Shiue H.S., Yang M.H., Chen C.J., et al. Plasma folate level, urinary arsenic methylation profiles and urothelial carcinoma susceptibility. Food Chem Toxicol 2008, 46:929-938.
78. Huang Z., Pei Q., Sun G., Zhang S., Linag J., Gao Y., et al. Low selenium status affects arsenic metabolites in an arsenic exposed population with skin lesions. Clin Chim Acta 2008, 387:139-144.
79. Hughes M. Arsenic toxicity and potential mechanisms of action. Toxicol Lett 2002, 133:1-16.
80. Hughes M. Biomarkers of exposure: a case study with inorganic arsenic. Environ Health Perspect 2006, 114:1790-1796.
81. Institut National de Veille Sanitaire (INVS) Chronic exposure to arsenic water and health risks. Review of epidemiological data. Quantitative assessment of health risks in Auvergne. Report 2002, 103. Accessible at:. http://www.invs.sante.fr/publications/2003/arsenic/index.html.
82. International Agence for Research on Cancer (I.A.R.C.) Monographs on the evaluation of carcinogenic risks to humans 2004, 84:526. Lyon (France).
83. Ishikawa H., Tian Y., Yamauchi T. Influence of gender, age and lifestyle factors on micronuclei frequency in healthy Japanese populations. J Occup Health 2003, 45:179-181.
84. Kapaj S., Peterson H., Liber K., Bhattacharya P. Human health effects from chronic arsenic poisoning-a review. J Environ Sci Health A Tox Hazard Subst Environ Eng 2006, 41:2399-2428.
85. Karagas M.R., Tosteson T.D., Blum J., Klaue B., Weiss J.E., Stannard V. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol 2000, 152:84-90.
86. Karagas M.R., Le C.X., Morris S., Blum J., Lu X., Spate V., et al. Markers of low level arsenic exposure for evaluating human cancer risks in a US population. Int J Occup Med Environ Health 2001, 14:171-175.
87. Karagas M.R., Stukel T.A., Morris J.S., Tosteson T.D., Weiss J.E., Spencer S.K., et al. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 2001, 153:559-565.
88. Kato K., Yamanaka K., Hasegawa A., Okada S. Active arsenic species produced by GSH-dependent reduction of dimethylarsinic acid cause micronuclei formation in peripheral reticulocytes of mice. Mutat Res 2003, 539:55-63.
89. Kenyon E.M., Del Razo L.M., Hughes M.F., Kitchin K.T. An integrated pharmacokinetic and pharmacodynamic study of arsenite action 2. Heme oxygenase induction in mice. Toxicology 2005, 206:389-401.
90. Kile M.L., Houseman E.A., Rodrigues E., Smith T.J., Quamruzzaman Q., Rahman M., et al. Toenail arsenic concentrations, GSTT1 gene polymorphism and arsenic exposure from drinking water. Cancer Epidemiol Biomarkers Prev 2005, 14:2419-2426.
91. Kile M.L., Hoffman E., Hsueh Y.M., Afroz S., Quamruzzaman Q., Rahman M., et al. Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect 2009, 117:455-460.
92. Kurttio P., Komulainen H., Hakala E., Kahelin H., Pekkanen J. Urinary excretion of arsenic species after exposure to arsenic present in drinking water. Arch Environ Contam Toxicol 1998, 34:297-305.
93. Le X.C., Ma M., Lu X., Cullen W.R., Aposhian H.V., Zheng B. Determination of monomethylarsonous acid, a key arsenic methylation intermediate in human urine. Environ Health Perspect 2000, 108:1015-1018.
94. Lewinska D., Palus J., Stepnik M., Dziubaltowska E., Beck J., Rydzynski K., et al. Micronucleus frequency in peripheral blood lymphocytes and buccal mucosa cells of copper smelter workers with special regard to arsenic exposure. Int Arch Occup Environ Health 2007, 80:371-380.
95. Li J.H., Rossman T.G. Mechanism of comutagenesis of sodium arsenite with n-methyl-n-nitrosurea. Biol Trace Elem Res 1989, 21:373-381.
96. Lin G.F., Du H., Chen J.G., Lu X.C., Kai J.X., Zhou Y.S., et al. Glutathione S-transferases M1 and T1 polymorphisms and arsenic content in hair and urine in two ethnic clans exposed to indoor combustion of high arsenic coal in Southwest Guizhou, China. Arch Toxicol 2007, 81:545-551.
97. Lindberg A.L., Goessler W., Gurzau E., Koppova K., Rudnai P., Kumar R., et al. Arsenic exposure in Hungary, Romania and Slovakia. J Environ Monit 2006, 8:203-208.
98. Lindberg A.L., Kumar R., Goessler W., Thirumaran R., Gurzau E., Koppova K., et al. Metabolism of low dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ Health Perspect 2007, 115:1081-1086.
99. Lindberg A.L., Ekstrom E.C., Nermell B., Rahman M., Lönnerdal B., Persson L.A., et al. Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh. Environ Res 2008, 106:110-120.
100. Liou S.H., Lung J.C., Chen Y.H., Yang T., Hsieh L.L., Chen C.J., et al. Increased chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res 1999, 59:1481-1484.
101. Liou S.H., Chen Y.H., Loh C.H., Yan T., Wu T.N., Chen C.J., et al. The association between frequencies of mitomycin C-induced sister chromatid exchange and cancer risk in arseniasis. Toxicol Lett 2002, 129:237-243.
102. Loffredo C.A., Aposhian H.V., Cebrian M.E., Yamauchi H., Silbergeld E.K. Variability in human metabolism of arsenic. Environ Res 2003, 92:85-91.
103. Mahata J., Basu A., Ghoshal S., Sarkar J.N., Roy A.K., Poddar G., et al. Chromosomal aberrations and sister chromatide exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res 2003, 534:133-143.
104. Mahata J., Chaki M., Ghosh P., Das L.K., Baidya K., Ray K., et al. Chromosomal aberrations in arsenic exposed human populations: a review with special reference to a comprehensive study in West Bengal, India. Cytogenet Genome Res 2004, 104:359-364.
105. Mahata J., Ghosh P., Sarkar J.N., Ray K., Natarajan A.T., Giri A.K. Effect of sodium arsenite on peripheral lymphocytes in vitro: individual susceptibility among a population exposed to arsenic through the drinking water. Mutagenesis 2004, 19:223-229.
106. Maki-Paakanen J., Kurttio P., Paldy A., Pekkanen J. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ Mol Mutagen 1998, 32:301-313.
107. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic affected areas in West Bengal, India. Chem Res Toxicol 2001, 14:371-378.
108. Mandal B.K., Ogra Y., Suzuki K.T. Speciation of arsenic in human nail and hair from arsenic affected area by HPLC inductively coupled argon plasma mass spectrometry. Toxicol Appl Pharmacol 2003, 189:73-83.
109. Mandal B.K., Ogra Y., Anzai K., Suzuki K.T. Speciation of arsenic in biological samples. Toxicol Appl Pharmacol 2004, 198:307-318.
110. Mandal B.K., Suzuki K.T., Anzai K. Impact of arsenic in foodstuffs on the people living in the arsenic-affected areas of West Bengal, India. J Environ Sci Health A Tox Hazard Subst Environ Eng 2007, 42:1741-1752.
111. Marks G.S. Exposure to toxic agents: the heme biosynthetic pathway and hemoproteins as indicator. Crit Rev Toxicol 1985, 15:151-179.
112. Marnell L.L., Garcia-Vargas G.G., Chowdbury U.K., Zakharyan R.A., Walsh B., Avram M.D., et al. Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles. Chem Res Toxicol 2003, 16:1507-1513.
113. Martinez V., Creus A., Venegas W., Arroyo A., Beck J.P., Gebel T.W., et al. Evaluation of micronucleus induction in a Chilean population environmentally exposed to arsenic. Mutat Res 2004, 564:65-74.
114. Martinez V., Creus A., Venegas W., Arroyo A., Beck J.P., Gebel T.W., et al. Micronuclei assessment in buccal cells of people environmentally to arsenic in northern Chile. Toxicol Lett 2005, 155:319-327.
115. Mc Carty K.M., Chen Y.C., Quamruzzaman Q., Rahman M., Mahiuddin G., Hsueh Y.M., et al. Arsenic methylation, GSTT1, GSTM1, GSPT1 polymorphisms and skin lesions. Environ Health Perspect 2007, 115:341-345.
116. Mc Carty K.M., Ryan L., Houseman E.A., Williams P.L., Miller D.P., Quamruzzaman Q., Rahman M., Mahiuddin G., Smith T., Gonzalez E., Su L., Christiani D.C. A case-control study of GST polymorphism and arsenic related skin lesions. Environ. Health. 2007, 6:5.
117. Mc Dorman E.W., Collins B.W., Allen J.W. Dietary folate deficiency enhances induction of micronuclei by arsenic in mice. Environ. Mol. Mutagen. 2002, 40:71-77.
118. Meyer N., Helynck B., Ledrans M., Le Goaster C., Kintz P., Michel A. Evaluation of biological impregnation of a population exposed to high concentrations of arsenic in drinking water, Ferrette, 1997. Rev Epidemiol Sante Publique 1999, 47:315-321.
119. Meza M.M., Kopplin M.J., Burgess J.L., Gandolfi A.J. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Mexico. Environ Res 2004, 96:119-126.
120. Meza M.M., Yu L., Rodriguez Y.Y., Guild M., Thompson D., Gandolfi A.J., et al. Developmental and genetic modulation of arsenic biotransformation: a gene by environmental interaction. Toxicol Appl Pharmacol 2007, 222:381-387.
121. Michaud D.S., Wright M.E., Cantor K.P., Taylor P.R., Virtamo J., Albanes D. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. Am J Epidemiol 2004, 160:853-859.
122. Milton A.H., Hasan Z., Shahidullah S.M., Sharmin S., Jakariya M.D., Rahman M., et al. Association between nutritional status and arsenicosis due to chronic arsenic exposure in Bangladesh. Int J Environ Health Res 2004, 14:99-108.
123. Mitra S.R., Mazumder D.N., Basu A., Block G., Haque R., Samanta S., et al. Nutritional factors and susceptibility to arsenic caused skin lesions in West Bengal, India. Environ Health Perspect 2004, 112:1104-1109.
124. Mizumura A., Watanabe T., Kobayashi Y., Hirano S. Identification of arsenite and arsenic diglutathione-binding proteins in human hepatocarcinoma cells. Toxicol Appl Pharmacol 2010, 242:119-125.
125. Moore M.R. A commentary on the impacts of metals and metalloids in the environment upon the metabolism of drugs and chemicals. Toxicol Lett 2004, 148:153-158.
126. Moore L.E., Smith A., Hopenhayn-Rich C., Biggs M.L., Kalman D., Smith M. Decrease in bladder cell micronucleus prevalence after intervention to lower the concentration of arsenic in drinking water. Cancer Epidemiol Biomarkers Prev 1997, 6:1051-1056.
127. Moore L.E., Smith A.H., Hopenhayn-Rich C., Biggs M.L., Kalman D.A., Smitj M.T. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol Biomarkers Prev 1997, 6:31-36.
128. Moore M.R., Harrington-Brock K., Doerr C.L. Relative genotoxic potency of arsenic and its methylated metabolites. Mutat Res 1997, 386:279-290.
129. Nandi D., Patra R.C., Swarup D. Arsenic residues inhair samples from cattle in some arsenic affected areas of West Bengal, India. Bull Environ Contam Toxicol 2005, 75:251-256.
130. Naranmandura H., Suzuki K.T. Formation of dimethylthioarsenicals in red blood cells. Toxicol Appl Pharmacol 2008, 227:390-399.
131. Naranmandura H., Suzuki N., Suzuki K.T. Trivalents arsenicals are bound to proteins during reductive methylation. Chem Res Toxicol 2006, 19:1010-1018.
132. Naranmandura H., Ogra Y., Iwata K., Lee J., Suzuki K.T., Weinfeld M., et al. Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells. Toxicol Appl Pharmacol 2009, 238:133-140.
133. Naranmandura H., Bu N., Suzuki K.T., Lou Y., Ogra Y. Distribution and speciation of arsenic after intravenous administration of monomethylthioarsonic acid in rats. Chemosphere 2010, 81:206-213.
134. Naranmandura H., Iwata K., Suzuki K.T., Ogra Y. Distribution and metabolism of four different dimethylated arsenicals in hamsters. Toxicol Appl Pharmacol 2010, 245:67-75.
135. Navas-Acien A., Umans J.G., Howard B.V., Goessler W., Francesconi K.A., Crainiceanu C.M., et al. Urine arsenic concentrations and species excretion in American Indian communities over a 10-year period: the strong heart study. Environ Health Perspect 2009, 117:1428-1433.
136. Nermell B., Lindberg A.L., Rahman M., Berglund M., Persson L.A., Arifeen S.E., et al. Urinary arsenic concentration adjustment factors and malnutrition. Environ Res 2008, 106:212-218.
137. Ng J.C., Johnson D., Imray P., Chiswell B., Moore M.R. Speciation of arsenic metabolites in the urine of occupational workers and experimental rats using an optimised hydride cold trapping method. Analyst 1998, 123:929-933.
138. Ng J.C., Wang J.P., Zheng B., Zhai C., Maddalena R., Liu F., et al. Urinary porphyrins as biomarkers for arsenic exposure among susceptible populations in Guizhou province, China. Toxicol Appl Pharmacol 2005, 206:176-184.
139. Nilsson R., Jha A.N., Zaprianov Z., Natarajan A.T. Chromosomal aberrations in humans exposed to arsenic in the Srednogorie area, Bulgaria. Fresenius Environ Bull 1993, 2:59-64.
140. Nordberg G.F. Biomarkers of exposure, effects and susceptibility in humans and their application in studies of interactions among metals in China. Toxicol Lett 2010, 192:45-49.
141. Norppa H., Bonassi S., Hansteen I.L., Hagmar L., Strömberg U., Rössner P., et al. Chromosomal aberrations ans SCEs as biomarkers of cancer risk. Mutat Res 2006, 600:37-45.
142. NRC Arsenic in drinking water 1999, National Academy Press, Washington, 310 pp.
143. NRC Arsenic in drinking water 2001 update 2001, National Research Council, Washington, DC, 244 pp.
144. Ostrosky-Wegman P., Gonsebatt M.E., Montero R., Vega L., Barba H., Espinosa J., et al. Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico. Mutat Res 1991, 250:477-482.
145. Paiva L., Martinez V., Creus A., Quinteros D., Marcos R. Sister chromatid exchange analysis in smelting plant workers exposed to arsenic. Environ. Mol. Mutagen. 2006, 47:230-235.
146. Palus J., Lewinska D., Dziubaltowska E., Stepnik M., Beck J., Rydzynski K., Nilsson R. DNA damage in leukocytes of workers occupationally exposed to arsenic in copper smelters. Environ. Mol. Mutagen. 2005, 46:81-87.
147. III) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 2000, 163:203-207.
148. Pi J., Kumagai Y., Sun G., Yamauchi H., Yoshida T., Iso H., et al. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic Biol Med 2000, 28:1137-1142.
149. Porter K.E., Basu A., Hubbard A.E., Bates M.N., Kalman D., Rey O., et al. Association of genetic variation in cystathionine-B-synthase. Environ Res 2010, 110:580-587.
150. Raab A., Feldmann J. Arsenic speciation in hair extracts. Anal Bioanal Chem 2005, 381:332-338.
151. Rael L.T., Ayala-Fierro F., Bar-Or R., Carter D.E., Barber D.S. Interaction of arsine with haemoglobin in arsine induced hemolysis. Toxicol Sci 2006, 90:142-148.
152. Rahman M.M., Ng J.C., Naidu R. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ Geochem Health 2009, 31(Suppl. 1):189-200.
153. Ramirez T., Garcia-Montalvo V., Wise C., Cea-Olivares R., Poirier L.A., Herrera L.A. S-adenosyl-l-methionine is able to reverse micronucleus formation induced by sodium arsenite and other cytoskeleton disrupting agents in cultured human cells. Mutat Res 2003, 528:61-74.
154. Raml R., Rumpler A., Goessler W., Vahter M., Li L., Ochi T., et al. Thio-dimethylarsinate is a common metabolite in urine samples from arsenic exposed women in Bangladesh. Toxicol Appl Pharmacol 2007, 222:374-380.
155. Samanta G., Sharma R., Roychowdhury T., Chakraborti D. Arsenic and other elements in hair, nails and skin-scales of arsenic victims in West Bengal, India. Sci Total Environ 2004, 326:33-47.
156. Schmitt M.T., Schreinemachers D., Wu K., Ning Z., Zhao B., Le X.C., et al. Human nails as a biomarker of arsenic exposure from well water in Inner Mongolia: comparing atomic fluorescence spectrometry and neutron activation analysis. Biomarkers 2005, 10:95-104.
157. Sekhar K.C., Chary N.S., Kamala C.T., Rao J.V., Balaram V., Anjaneyulu Y. Risk assessment and pathway study of arsenic in industrially contamined sites of Hyderabad: a case study. Environ Int 2003, 29:601-611.
158. Shibata Y., Yoshinage J., Morita M. Detection of arsenobetaine in human blood. Appl Organometal Chem 1994, 8:249-251.
159. Shraim A., Cui X., Li S., Ng J.C., Wang J., Jin Y., et al. Arsenic speciation in the urine and hair of individuals exposed to airborne arsenic through coal-burning in Guizhou, PR China. Toxicol Lett 2003, 137:35-48.
160. Slejkovec Z., Falnoga I., Goessler W., van Elteren J., Raml R., Podgornik H., et al. Analytical artefacts in the speciation of arsenic in clinical samples. Anal Chim Acta 2008, 607:83-91.
161. Slotnick M.J., Nriagu J.O. Validity of human nails as a biomarker of arsenic and selenium exposure: a review. Environ Res 2006, 102:125-139.
162. Slotnick M.J., Meliker J.R., Ruskin G.A., Ghosh D., Nriagu J.O. Toenails as a biomarker of inorganic arsenic from drinking water and foods. J Toxicol Environ Health A 2007, 70:148-158.
163. Slotnick M.J., Meliker J.R., Nriagu J.O. Intra-individual variability in toenail arsenic concentrations in a Michigan population USA. J Expo Sci Environ Epidemiol 2008, 18:149-157.
164. Spallholz J.E., Boylan L.M., Palace V., Chen J., Smith L., Rahman M.M., et al. Arsenic and selenium in human hair: a comparison of five countries with and without arsenicosis. Biol Trace Elem Res 2005, 106:133-144.
165. States J.C., Srivastava S., Chen Y., Barchowski A. Arsenic and cardiovascular disease. Toxicol Sci 2009, 107(2):312-323.
166. Steinmaus C., Carrigan K., Kalman D., Atallah R., Yuan Y., Smith A.H. Dietary intake and arsenic methylation in a US population. Environ Health Perspect 2005, 113:1153-1159.
167. Steinmaus C., Yuan Y., Kalman D., Atallah R., Smith A.H. Intraindividual variability in arsenic methylation in a US population. Cancer Epidemiol Biomarkers Prev 2005, 14:919-924.
168. Steinmaus C., Moore L.E., Shipp M., Kalman D., Rey O.A., Biggs M.L., et al. Genetic polymorphism in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic. J Toxicol Environ Health A 2007, 70:159-170.
169. Steinmaus C., Yuan Y., Kalman D., Rey O.A., Skibola C.F., Dauphine D., et al. Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina. Toxicol Appl Pharmacol 2010, 247:138-145.
170. Styblo M., Del Razo L.M., Vega L., Germolec D.R., Le Cluyse E.L., Hamilton G.A., et al. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 2000, 74:289-299.
171. Sun G., Xu Y., Li X., Jin Y., Li B., Sun X. Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China. Environ Health Perspect 2007, 115:648-652.
172. Surrallès J., Natarajan A.T. Human lymphocytes micronucleus assay in Europe. An international survey. Mutat Res 1997, 392:165-174.
173. Suwazono Y., Akesson A., Alfven T., Jarup L., Vahter M. Creatinine versus specific gravity adjusted urinary cadmium concentrations. Biomarkers 2005, 10:117-126.
174. Suzuki K.T., Mandal B.K., Ogra Y. Speciation of arsenic in body fluids. Talanta 2002, 58:111-119.
175. Suzuki K.T., Iwata K., Naranmandura H., Suziki N. Metabolic differences between two dimethylthioarsenicals in rats. Toxicol Appl Pharmacol 2007, 218:166-173.
176. Tabata H., Anwar M., Horai S., Ando T., Nakano A., Wakamiya J., et al. Toenail arsenic levels among residents in Amami-Oshima Island, Japan. Environ Sci 2006, 13:149-160.
177. Tchounwou P.B., Centeno J.A., Patlolla A.K. Arsenic toxicity, mutagenesis and carcinogenesis-a health risk assessment and management approach. Mol Cell Biochem 2004, 255:47-55.
178. Telolahy P., Javelaud B., Cluet J., de Ceaurriz J., Boudene C. Urinary excretion of porphyrins by smelter workers chronically exposed to arsenic dust. Toxicol Lett 1993, 66:89-95.
179. Thomas D.J. Molecular processes in cellular arsenic metabolism. Toxicol Appl Pharmacol 2007, 222:365-373.
180. Thomas D.J. Arsenolysis and thiol-dependant arsenate reduction. Toxicol Sci 2010, 117:249-252.
181. Thomas D.J., Styblo M., Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 2001, 176:126-144.
182. Thomas D.J., Waters S.B., Styblo M. Elucidating the pathway for arsenic methylation. Toxicol Appl Pharmacol 2004, 198:319-326.
183. Thomas D.J., Li J., Waters S., Xing W., Adair B.M., Drobna Z., et al. Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp Biol Med 2007, 232:3-13.
184. Tian D., Ma H., Feng Z., Xia Y., Le X.C., Ni Z., et al. Analyses of micronuclei in exfoliated epithelial cells from individuals chronically exposed to arsenic via drinking water in Inner Mongolia, China. J Toxicol Environ Health A 2001, 64:473-484.
185. Tseng C.H. Arsenic methylation, urinary arsenic metabolites and human diseases: : current perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2007, 25:1-22.
186. Tseng C.H., Huang Y.K., Huang Y.L., Chung C.J., Yang M.H., Chen C.J., et al. Arsenic exposure, urinary arsenic speciation and peripheral vascular disease in blackfoot disease hyperendemic villages in Taïwan. Toxicol Appl Pharmacol 2005, 206:299-308.
187. Uchino T., Roychowdbury T., Ando M., Tokunaga H. Intake of arsenic from water, food composites and excretion through urine, hair from a studied population in West Bengal, India. Food Chem Toxicol 2006, 44:455-461.
188. US EPA An exposure and risk assessment for arsenic. Report EPA 440/4-85-005 1982, U.S.Environmental Protection Agency, Washington, D.C.
189. Vahter M. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol Lett 2000, 112-113:209-217.
190. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002, 181-182:211-217.
191. Vahter M. Interactions between arsenic induced toxicity and nutrition in early life. J Nutr 2007, 137(12):2798-2804.
192. Vahter M., Concha G. Role of the metabolism in arsenic toxicity. Pharmacol Toxicol 2001, 89:1-5.
193. Vahter M., Chappell W.R., Abernathy C.O., Calderon R.L. Variation in human metabolism of arsenic. Arsenic exposure and health effects 1999, 267-279. Elsevier Science Ltd, Oxford.
194. Vahter M., Concha G., Nermell B. Factors influencing arsenic methylation in humans. J Trace Elemt Exp Med 2000, 13:173-184.
195. Vahter M., Björkmann L., Goessler W. Concentrations of biomarkers in spot urine samples need adjustment for variation in dilution. Comment on: "distribution of urinary selenium and arsenic among pregnant women exposed to arsenic in drinking water". Environ Res 2007, 104:312-313.
196. Valenzuela O., Borja-Aburto V.H., Garcia-Vargas G.G., Cruz-Gonzalez M.B., Garcia-Montalvo E.A., Calderon-Aranda E.S., et al. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ Health Perspect 2005, 113:250-254.
197. Van Halem D., Bakker S.A., Amy G.L., van Dijk J.C. Arsenic in drinking water: not just a problem for Bangladesh. Drinki. Water. Eng. Sci. Discuss. 2009, 2:51-64.
198. Vuyyuri S.B., Ishaq M., Kuppala D., Grover P., Ahuja Y.R. Evaluation of micronucleus frequencies and DNA damage in glass workers exposed to arsenic. Environ Mol Mutagen 2006, 47:562-570.
199. Wang J.P., Qi L., Zheng B., Liu F., Moore M.R., Ng J.C. Porphyrins as early biomarkers for arsenic exposure in animals and humans. Cell Mol Biol 2002, 48:835-843.
200. Wang J.P., Qi L., Moore M.R., Ng J.C. A review of animal models for the study of arsenic carcinogenesis. Toxicol Lett 2002, 133:17-31.
201. Warner M.L., Moore L.E., Smith M.T., Kalman D.A., Fannig E., Smith A.H. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic contaminated water in Nevada. Cancer Epidemiol Biomarkers Prev 1994, 3:583-590.
202. WHO Guidelines for drinking water quality volume 3 Available on. http://www.who.int/water_sanitation_health/dwq/dwqtraining/en/index.html.
203. WHO Guidelines for drinking water quality. Vol 1 2008, http://www.who.int/water_sanitation_health/dwq/en/gdwq3_12.pdf, 3rd ed. incorporating 1st and 2nd addenda.
204. Wickre J.B., Folt C.L., Sturup S., Karagas M.R. Environmental exposure and fingernail analysis of arsenic and mercury in chidren and adults in a Nicaraguan gold minig community. Arch Environ Health 2004, 59:400-409.
205. Wilhelm M., Ewers U., Schulz C. Revised and new reference values for some trace elements in blood and urine for human biomonitoring in environmental medicine. Int J Hyg Environ Health 2004, 207:69-73.
206. Wilhelm M., Pesch B., Wittsiepe J., Jakubis P., Miskovic P., Keegan T., et al. Comparison of arsenic levels in fingernails with urinary arsenic species as biomarkers of arsenic exposure in residents living close to a coal-burning power plant in Prievidza District, Slovakia. J Expo Anal Environ Epidemiol 2005, 15:89-98.
207. Wood T.C., Salavagionne O.E., Mukherjee B., Wang L., Klumpp A.F., Thomae B.A., et al. Human arsenic methyltransferase (As3MT) pharmacogenetics. J Biol Chem 2006, 11:7364-7373.
208. Wu M.M., Chiou H.Y., Wang T.W., Hsueh Y.M., Wang I.H., Chen C.J., et al. Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. Environ Health Perspect 2001, 109:1011-1017.
209. Wu M.M., Chiou H.Y., Ho I.C., Chen C.J., Lee T.C. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic exposed humans subjects. Environ Health Perspect 2003, 111:1429-1438.
210. Yamamoto S., Konishi Y., Matsuda T., Murai T., Shibata M.A., Matsui-Yuasa I., et al. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pre-treatment with five carcinogens. Cancer Res 1995, 55:1271-1276.
211. Yanez J., Fierro V., Mansilla H., Figueroa L., Cornejo L., Barnes R.M. Arsenic speciation in human hair: a new perspective for epidemiological assessment in chronic arsenicism. J Environ Monit 2005, 7:1335-1341.
212. Yoshida K., Kuroda K., Zhou X., Inoue Y., Date Y., Wanibuchi H., et al. Urinary sulfur-containing metabolite produced by intestinal bacteria following oral administration of dimethylarsinic acid to rats. Chem Res Toxicol 2003, 16:1124-1129.
213. Yu Y., Hsu K.H., Chen C.J., Froines J.R. Arsenic methylation capacity and skin cancer. Epidemiol Biomarkers Prev 2000, 9:1259-1262.